drugset / Trial / NCT01606475

Islet Transplant for Type 1 or Surgical Diabetes

NCT01606475

Expanded access No longer available University of Minnesota

Summary

The purpose of this study is to evaluate the safety and efficacy of islet transplants from human cadaver donors into type 1 or surgical diabetes mellitus patients who experience frequent acute or advanced chronic complications but do not qualify for other islet transplant trials. Under this protocol, patients may receive intraportal alloislet transplant under one of the following scenarios: 1. islet transplant alone 2. simultaneous islet-kidney transplant, or 3)islet after kidney transplant.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Allogeneic Islets of Langerhans Cell therapy 5000 unknown Other